You are here

Sovaldi

Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead

Fierce Pharma

Tue, 01/19/21 - 09:18 pm

Gilead Sciences

Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?

Pharmaforum

Fri, 02/21/20 - 10:31 am

Gilead Sciences

Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry

Endpoints

Tue, 08/14/18 - 06:38 pm

Gilead Sciences

Gilead wins reprieve in Merck's $2.5B patent lawsuit

Biopharma Dive

Thu, 02/22/18 - 09:52 am

Gilead Sciences

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

Reuters

Sun, 02/18/18 - 10:10 am

Gilead Sciences

Dogged by AbbVie's new share-stealing Mavyret, Gilead's hep C forecast comes in far short

Fierce Pharma

Thu, 02/8/18 - 09:14 am

Gilead Sciences

Gilead prices hepatitis C giant Sovaldi in China at one-fifth the U.S. price: report

Fierce Pharma

Tue, 11/28/17 - 11:07 am

Gilead Sciences

The 1 Thing Missing From Gilead Sciences' 2018 Priority List

Motley Fool

Tue, 11/21/17 - 10:37 pm

Gilead Sciences

Gilead nabs Chinese nod for Sovaldi, eyeing world's largest hepatitis C patient base

Fierce Pharma

Tue, 09/26/17 - 10:03 am

Gilead Sciences

How AbbVie Could Hammer Gilead's Hepatitis C Franchise

Investors Business Daily

Wed, 07/19/17 - 07:55 pm

Gilead Sciences

When It Comes To Abusive Drug Pricing, Don't Confuse Shkreli With Hep C Drugs

Forbes

Wed, 07/19/17 - 09:58 am

Gilead Sciences

Gilead works on lifecycle management for Sovaldi as Hep C franchise wanes

BioPharma Dive

Thu, 04/13/17 - 11:48 am

Gilead Sciences

Gilead Hep C Drugs Get Supplemental FDA Nod

Investopedia

Sat, 04/8/17 - 01:11 pm

Gilead Sciences

Gilead pushes hep C testing in baby boomers as its blockbusters plummet

Fierce Pharma

Thu, 02/23/17 - 09:21 am

Gilead Sciences

DTC advertising

Gilead cured hepatitis C. That’s become its biggest problem

Marketwatch

Wed, 02/8/17 - 09:27 pm

Gilead Sciences

Gilead’s Biggest Blockbusters Are Fading Fast, Biotech Warns

Bloomberg

Wed, 02/8/17 - 09:21 am

Gilead Sciences

Has Gilead Sciences' Cash Cow Finally Hit Bottom?

Motley Fool

Mon, 01/23/17 - 10:26 am

Gilead Sciences

The Most Expensive Drugs of 2016

Motley Fool

Mon, 12/19/16 - 11:32 am

Gilead Sciences

Bristol-Myers Squibb

Gilead’s Patent Loss to Merck Started With a Broken Friendship

Bloomberg

Mon, 12/19/16 - 10:55 am

Gilead Sciences

Merck Wins Record $2.5 Billion Patent Verdict Against Gilead

Bloomberg

Fri, 12/16/16 - 09:51 am

Gilead Sciences

Pages